Authors:
Hausler, MG
Jaeken, J
Monch, E
Ramaekers, VT
Citation: Mg. Hausler et al., Phenotypic heterogeneity and adverse effects of serine treatment in 3-phosphoglycerate dehydrogenase deficiency: Report on two siblings, NEUROPEDIAT, 32(4), 2001, pp. 191-195
Authors:
Obermayer, N
Busse, B
Grunwald, A
Monch, E
Muller, C
Neuhaus, P
Gerlach, JC
Citation: N. Obermayer et al., Biochemical characterization of bioreactors for hybrid liver support: Serum-free liver cell coculture of nonparenchymal and parenchymal cells, TRANSPLAN P, 33(1-2), 2001, pp. 1930-1931
Authors:
Hennermann, JB
Vetter, B
Wolf, C
Windt, E
Buhrdel, P
Seidel, J
Monch, E
Kulozik, AE
Citation: Jb. Hennermann et al., Phenylketonuria and hyperphenylalaninemia in eastern Germany: A characteristic molecular profile and 15 novel mutations, HUM MUTAT, 15(3), 2000, pp. 254-260
Authors:
Hundsdoerfer, P
Vetter, B
Stover, B
Bassir, C
Monch, E
Ziemer, S
Kulozik, AE
Citation: P. Hundsdoerfer et al., Design of a prospective neonatal cohort study of homozygous and double heterozygous Factor V Leiden and Factor II G20210A, KLIN PADIAT, 212(4), 2000, pp. 159-162
Authors:
Burgard, P
Bremer, HJ
Buhrdel, P
Clemens, PC
Monch, E
Przyrembel, H
Trefz, FK
Ullrich, K
Citation: P. Burgard et al., Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997, EUR J PED, 158(1), 1999, pp. 46-54